Cargando…
Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance
BACKGROUND: Despite the various strategies undertaken in the clinical practice, the mortality rate due to antibiotic-resistant microbes has been markedly increasing worldwide. In addition to multidrug-resistant (MDR) microbes, the “ESKAPE” bacteria are also emerging. Of course, the infection caused...
Autores principales: | Peraman, Ramalingam, Sure, Sathish Kumar, Dusthackeer, V. N. Azger, Chilamakuru, Naresh Babu, Yiragamreddy, Padmanabha Reddy, Pokuri, Chiranjeevi, Kutagulla, Vinay Kumar, Chinni, Santhivardhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928709/ https://www.ncbi.nlm.nih.gov/pubmed/33686369 http://dx.doi.org/10.1186/s43094-021-00196-5 |
Ejemplares similares
-
Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics
por: Peraman, Ramalingam, et al.
Publicado: (2015) -
Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c
por: Nirmal, Christy Rosaline, et al.
Publicado: (2023) -
Drug resistance among extrapulmonary TB patients: Six years experience from a supranational reference laboratory
por: Dusthackeer, Azger, et al.
Publicado: (2015) -
Drug Discovery Prospect from Untapped Species: Indications from Approved Natural Product Drugs
por: Zhu, Feng, et al.
Publicado: (2012) -
New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents
por: Peraman, Ramalingam, et al.
Publicado: (2016)